Skip to main content

PC-03 Antenatal Steroids

CBE ID
0476
1.4 Project
Perinatal and Women's Health
Endorsed
Endorsement Status
Endorsement Removed
1.1 New or Maintenance
Maintenance
E&M Cycle
Fall 2020
Is Under Review
No
1.3 Measure Description

This measure assesses patients at risk of preterm delivery at >=24 and <34 weeks gestation receiving antenatal steroids prior to delivering preterm newborns. This measure is a part of a set of five nationally implemented measures that address perinatal care (PC-01: Elective Delivery, PC-02: Cesarean Birth, PC-04: Health Care-Associated Bloodstream Infections in Newborns, PC-05: Exclusive Breast Milk Feeding; Beginning 1/1/2019 PC-06 Unexpected Complications in Term Newborns will be added).

    • 1.14 Numerator

      Patients with antenatal steroids initiated prior to delivering preterm newborns (refer to Appendix C, Table 11.0, antenatal steroid medications).

    • 1.15 Denominator

      Patients delivering live preterm newborns with >=24 and <34 weeks gestation completed with ICD-10-PCS Principal or Other Procedure Codes for delivery as defined in Appendix A, Table 11.01.1.

    • Exclusions

      • Less than 8 years of age
      • Greater than or equal to 65 years of age
      • Length of Stay >120 days
      • Documented Reason for Not Initiating Antenatal Steroids
      • ICD-10-CM Principal Diagnosis Code or ICD-10-CM Other Diagnosis Codes for fetal demise as defined in Appendix A, Table 11.09.1.
      • Gestational Age < 24 or >= 34 weeks or UTD

    • Most Recent Endorsement Activity
      Measure Retired and Endorsement Removed Perinatal and Women's Health Fall Cycle 2020
      Initial Endorsement
      Last Updated
      Removal Date
    • Steward
      The Joint Commission
      Steward Organization Email
      [email protected]
      Steward Organization Copyright

      No royalty or use fee is required for copying or reprinting this manual, but the following are required as a condition of usage: 1) disclosure that the Specifications Manual is periodically updated, and that the version being copied or reprinted may not be up-to-date when used unless the copier or printer has verified the version to be up-to-date and affirms that, and 2) users participating in Joint Commission accreditation, including ORYX® vendors, are required to update their software and associated documentation based on the published manual production timelines.